Seaport Therapeutics, Inc. - Voting Common Stock, $0.001 par value per share (SPTX)

CUSIP: 81221K108

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 5 signals
Share change
+1,061
SEC-reported price per share
$20.17
Number of holders
3
Value change
+$21,400
Number of buys
3
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
53,477,606

Security key

81221K108

Report period

Q3 2026

Institutions

3

Top holders

3

Ownership snapshot

Top reported holders of SPTX - Seaport Therapeutics, Inc. - Voting Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PureTech LYT, Inc.
Disclosed value leader
PureTech LYT, Inc.
Comparable rows
3/15
Latest evidence
30 Jun 2026
13D/G 3/4/5 13F Lead comparable stake: 31% 12 rows are not safely comparable across share classes. 13D/G row: PureTech LYT, Inc. Showing 1-6 of 15 holder rows.

Quick read

PureTech LYT, Inc. leads the comparable SEC ownership view at 31%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PureTech LYT, Inc.'s linked filing trail.
Comparable ownership Top 3
PureTech LYT, Inc. 31%
Zohar Daphne 9.1%
Steven M. Paul 6.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PureTech LYT, Inc.
13D/G 3/4/5
PureTech Health plc · 10%+ Owner
31%
Reported 13D/G · 30 Jun 2026
$335,368,761
16,685,013 shares
$0 30 Jun 2026
Zohar Daphne
13D/G 3/4/5
Chief Executive Officer, Director
9.1%
Reported 13D/G · 30 Jun 2026
$105,032,490
5,225,497 shares
$0 30 Jun 2026
Steven M. Paul
13D/G 3/4/5
PAUL STEVEN M · Director
6.3%
Reported 13D/G · 30 Jun 2026
$70,686,032
3,516,718 shares
$0 30 Jun 2026
GENERAL ATLANTIC, L.P.
13F 3/4/5
Company · Director, 10%+ Owner
—
denominator unverified
$132,526,361
6,101,582 shares
— 30 Jun 2026
PureTech Health plc
3/4/5
10%+ Owner
—
denominator unverified
—
16,685,013 shares
— 04 May 2026
ARCH Venture Fund XII, L.P.
3/4/5
10%+ Owner
—
denominator unverified
—
6,294,951 shares
— 04 May 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
3
Shares
2,492
Rows available
3
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
54
Q3 2026 holders
3
Holder diff
-51
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .